1. Landsberg L, Young JB. Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson L, editors. Pheochromocytoma. Harrison's principles of internal medicine. 2004. 16th Ed. New York: McGraw-Hill;2148–2152.
2. Salazar A, Naik A, Rolston D. Intestinal pseudoobstruction as a presenting feature of a pheochromocytoma. J Clin Gastroenterol. 2001. 33:253–254.
3. Lenz T, Gossmann J, Schulte K, Salewski L, Geiger H. Diagnosis of pheochromocytoma. Clin Lab. 2002. 48:5–18.
4. Browers F, Lenders J, Eisenhofer G, Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord. 2003. 4:121–128.
5. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet. 2003. 361:2059–2067.
6. Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B, Kirste G. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med. 1993. 329:1531–1538.
7. Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. von Recklinghausen's disease and pheochromocytomas. J Urol. 1999. 162:1582–1586.
8. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C, Eng C. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002. 346:1459–1466.
9. Hayes W, Davidson A, Grimley P, Hartman D. Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT findings. Am J Roentgenol. 1990. 155:1247–1250.
10. Kim WY, Kang KJ, Lim TJ. Functioning paraganglioma manifested cerebral hemorrhage and combined with coronary arteriovenous fistula. J Korean Surg Soc. 2002. 63:517–520.
11. Young WF Jr. Paragangliomas: clinical overview. Ann N Y Acad Sci. 2006. 1073:21–29.
12. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg. 1990. 102:382–390.
13. Kim YT, Song YK, Lee KU, Lee M, Park KC, Yu ES, Lee JH, Jin TS. A case of paraganglioma manifested as intestinal pseudo-obstruction. Korean J Intern Med. 1990. 40:708–711.
14. Hahimoto Y, Motoyoshi S, Maruyama H, Sakakida M, Yano T, Yamaguchi K, Goto K, Sugihara S, Takano S, Kambara T, Shichiri M. The treatment of pheochromocytoma associated with pseudo-obstruction and perforation of the colon, hepatic failure, and DIC. Jpn J Med. 1990. 29:341–346.
15. Murakami S, Okushiba S, Ohno K, Ito K, Satou K, Sugiura H, Morikawa T, Furukawa K, Kondo S, Katoh H, Nihei K. Malignant pheochromocytoma associated with pseudo-obstruction of the colon. J Gastroenterol. 2003. 38:175–180.
16. Cryer P. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 1980. 303:436–444.
17. Vance JE, Buchanan KD, O'Hara D. Insulin and glucagon responses in subjects with pheochromocytoma: Effect of alpha adrenergic blockade. J Clin Endocrinol Metab. 1969. 29:911–916.
18. Stenstrom G, Sjostrom L, Smith U. Diabetes mellitus in phaeochromocytoma: fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma. Acta Endocrinol. 1984. 106:511–515.
19. Ball AB, Tait DM, Fisher C, Sinnett HD, Harmer CL. Treatment of metastatic paraganglioma by surgery, radiotherapy and I-131 MIBG. Eur J Surg Oncology. 1991. 17:543–546.
20. Sisson JC, Shapiro B, Beierwaltes WH, Glowniak JV, Nakajo M, Mangner TJ, Carey JE, Swanson DP, Copp JE, Satterlee WG, Wieland DM. Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med. 1984. 24:197–206.